Analyst call with Allergan execs stokes anticipation of a plan to split the company in ‘a month or two’

So what’s up at Allergan?

Earlier this week the ubiquitous Evercore ISI analyst Umer Raffat was on the line with company executives to probe into the latest on the numbers as well as CEO Brent Saunders’ recent declaration that he’d be doing something definitive to help long-suffering investors who have watched their shares dwindle in value.